Caverton Offshore Support Group Plc (NGX:CAVERTON)

Sage Therapeutics Revenue

Caverton Offshore Support Group had revenue of 7.13B NGN in the quarter ending June 30, 2025, a decrease of -24.83%. This brings the company's revenue in the last twelve months to 37.51B, down -7.37% year-over-year. In the year 2024, Caverton Offshore Support Group had annual revenue of 40.18B with 25.61% growth.

• Revenue (ttm): 37.51B
• Revenue Growth: -7.37%
• P/S Ratio: 0.63
• Revenue / Employee: 198.47M
• Employees: 189
• Market Cap: 23.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.18B	8.19B	25.61%
Dec 31, 2023	31.99B	2.76B	9.45%
Dec 31, 2022	29.23B	-5.53B	-15.91%
Dec 31, 2021	34.76B	2.59B	8.04%
Dec 31, 2020	32.17B	-2.81B	-8.02%